Ling Lin
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 2%
- Immune cells in cancer
Papers in
-
- RNA modifications and cancer 5
- Circular RNAs in diseases 5
- Co-authors
- Taisheng Li (4 shared papers)Wei Cao (4 shared papers)Erwei Song (8 shared papers)Lianfeng Lu (2 shared papers)Yongsong Chen (17 shared papers)Jingqi Chen (2 shared papers)Mei Yang (2 shared papers)Herui Yao (6 shared papers)
- Journals
- Human Immunology (7 papers)PLoS ONE (4 papers)Infection and Drug Resistance (2 papers)Arthritis Research & Therapy (2 papers)Oncogene (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ling Lin
101 papers receiving 5.4k citations
Ling Lin's Hit Papers
Peers
Comparison fields: 5 of 138
- Cancer Research 1.2k
- Immunology 1.1k
- Infectious Diseases 792
- Oncology 929
- Molecular Biology 2.1k
Countries citing papers authored by Ling Lin
This map shows the geographic impact of Ling Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Lin more than expected).
Fields of papers citing papers by Ling Lin
This network shows the impact of papers produced by Ling Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Lin. The network helps show where Ling Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia Hit paper breakdown → | 2020 | 657 |
| 2 | A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis Hit paper breakdown → | 2014 | 617 |
| 3 | Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells Hit paper breakdown → | 2011 | 586 |
| 4 | 2020 | 301 | |
| 5 | 1998 | 273 | |
| 6 | 2011 | 217 | |
| 7 | 2017 | 177 | |
| 8 | 2012 | 166 | |
| 9 | 1997 | 162 | |
| 10 | 2015 | 160 | |
| 11 | 2020 | 154 | |
| 12 | 2021 | 145 | |
| 13 | Inflammation in atherosclerosis: pathophysiology and mechanisms Hit paper breakdown → | 2024 | 143 |
| 14 | 2013 | 109 | |
| 15 | 2013 | 101 | |
| 16 | 2013 | 88 | |
| 17 | 2020 | 85 | |
| 18 | 2014 | 84 | |
| 19 | 2018 | 73 | |
| 20 | 2014 | 59 |
About Ling Lin
Ling Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Immunology, Oncology and Cancer Research, having authored 109 papers that have together received 5.5k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (12 papers), Immune Cell Function and Interaction (8 papers), Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), RNA modifications and cancer (5 papers), Circular RNAs in diseases (5 papers) and Spondyloarthritis Studies and Treatments (4 papers). The work is most often cited by research in Cancer Research (1.2k citations), Immunology (1.1k citations), Infectious Diseases (792 citations), Oncology (929 citations) and Molecular Biology (2.1k citations). Ling Lin has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Taisheng Li, Wei Cao, Erwei Song, Lianfeng Lu, Yongsong Chen, Jingqi Chen, Mei Yang, Herui Yao, Qiang Liu and Tao‐Sheng Li. Their work appears in journals such as Human Immunology, PLoS ONE, Infection and Drug Resistance, Arthritis Research & Therapy and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.